Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.

PubWeight™: 2.27‹?› | Rank: Top 2%

🔗 View Article (PMID 16489055)

Published in Cancer Res on February 15, 2006

Authors

Shelley S Tworoger1, Patrick Sluss, Susan E Hankinson

Author Affiliations

1: Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. nhsst@channing.harvard.edu

Articles citing this

Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study. Am J Epidemiol (2008) 2.25

Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis (2010) 1.79

Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol (2016) 1.43

Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk. Fam Cancer (2007) 1.43

Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res Ther (2008) 1.31

Body size across the life course, mammographic density, and risk of breast cancer. Am J Epidemiol (2011) 1.28

A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res (2013) 1.25

Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res (2013) 1.23

Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am J Hum Genet (2015) 1.23

Inflammation and early-life abuse in women. Am J Prev Med (2012) 1.20

Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer (2009) 1.16

Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res (2009) 1.15

Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 1.15

Male breast cancer: an update in diagnosis, treatment and molecular profiling. Maturitas (2010) 1.11

STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. Mol Cell Biol (2013) 1.09

Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer. Mol Cell Endocrinol (2013) 1.04

Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk. Breast Cancer Res Treat (2008) 1.03

A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer. Am J Epidemiol (2013) 1.01

Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res (2011) 1.01

Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am J Epidemiol (2011) 1.00

Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res (Phila) (2011) 1.00

Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone. Daru (2013) 0.97

Global profiling of prolactin-modulated transcripts in breast cancer in vivo. Mol Cancer (2013) 0.90

Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer (2012) 0.90

Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies. Breast Cancer Res Treat (2012) 0.89

The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial. Curr Oncol (2007) 0.89

Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland. Br J Cancer (2010) 0.89

Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II. Breast Cancer Res (2012) 0.88

Circulating sex hormones and terminal duct lobular unit involution of the normal breast. Cancer Epidemiol Biomarkers Prev (2014) 0.88

Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer. Breast Cancer Res Treat (2014) 0.87

The risk for breast cancer is not evidently increased in women with hyperprolactinemia. Pituitary (2010) 0.86

Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II. Cancer Causes Control (2014) 0.86

Endogenous levels of circulating androgens and risk of Crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts. Inflamm Bowel Dis (2015) 0.86

Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics. Cancer Epidemiol Biomarkers Prev (2015) 0.85

Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study. Breast Cancer Res (2015) 0.85

Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study. BMC Womens Health (2014) 0.84

Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer. Cancer Causes Control (2008) 0.84

Migraine and breast cancer risk: a prospective cohort study and meta-analysis. J Natl Cancer Inst (2014) 0.82

Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women. Cancer Causes Control (2013) 0.82

Leptin and leptin receptor genes in relation to premenopausal breast cancer incidence and grade in Caucasian women. Breast Cancer Res Treat (2011) 0.82

Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2013) 0.82

Body size in relation to urinary estrogens and estrogen metabolites (EM) among premenopausal women during the luteal phase. Horm Cancer (2012) 0.81

Bioactive prolactin levels and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2014) 0.81

Associations between dietary acrylamide intake and plasma sex hormone levels. Cancer Epidemiol Biomarkers Prev (2013) 0.81

Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies. Breast Cancer Res Treat (2015) 0.81

Dietary fat, fiber, and carbohydrate intake and endogenous hormone levels in premenopausal women. Horm Cancer (2010) 0.81

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer. Front Oncol (2012) 0.80

Plasma enterolactone and breast cancer risk in the Nurses' Health Study II. Breast Cancer Res Treat (2013) 0.79

Derivation and validation of homocysteine score in u.s. Men and women. J Nutr (2014) 0.79

Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk. Int J Mol Epidemiol Genet (2010) 0.79

Genetic variability in IGF-1 and IGFBP-3 and body size in early life. BMC Public Health (2012) 0.78

Plasma prolactin and breast cancer risk: a meta- analysis. Sci Rep (2016) 0.77

Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland. Horm Cancer (2013) 0.77

Childhood Physical and Sexual Abuse History and Leukocyte Telomere Length among Women in Middle Adulthood. PLoS One (2015) 0.76

An Increase in Dietary Quality Is Associated with Favorable Plasma Biomarkers of the Brain-Adipose Axis in Apparently Healthy US Women. J Nutr (2016) 0.76

Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II. Cancer Epidemiol Biomarkers Prev (2014) 0.76

Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism. Thromb Haemost (2016) 0.76

Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies. Breast Cancer Res Treat (2014) 0.76

Adolescent fiber intake and mammographic breast density in premenopausal women. Breast Cancer Res (2016) 0.75

Mammographic density and breast cancer risk: a mediation analysis. Breast Cancer Res (2016) 0.75

Duarte galactose-1-phosphate uridyl transferase genotypes are not associated with ovarian cancer risk. Fertil Steril (2012) 0.75

A comprehensive survey of genetic variation in 20,691 subjects from four large cohorts. PLoS One (2017) 0.75

Antidepressant use and circulating prolactin levels. Cancer Causes Control (2016) 0.75

Alcohol Consumption and Urinary Estrogens and Estrogen Metabolites in Premenopausal Women. Horm Cancer (2016) 0.75

A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis. Am J Epidemiol (2015) 0.75

Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II. Breast Cancer Res Treat (2016) 0.75

Identification and Characterization of a Novel Association between Dietary Potassium and Risk of Crohn's Disease and Ulcerative Colitis. Front Immunol (2016) 0.75

Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev (2017) 0.75

Deep targeted sequencing of 12 breast cancer susceptibility regions in 4611 women across four different ethnicities. Breast Cancer Res (2016) 0.75

Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis (2017) 0.75

Articles by these authors

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30

Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22

Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86

Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet (2008) 4.57

Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54

Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50

Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst (2006) 3.65

Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst (2004) 3.28

Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 3.11

Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet (2009) 3.06

The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95

Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med (2010) 2.95

Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst (2003) 2.92

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80

Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2004) 2.75

Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol (2004) 2.72

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72

Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66

Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum (2004) 2.62

Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr (2007) 2.56

Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation (2003) 2.52

A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol (2007) 2.50

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.37

Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34

Night work and risk of breast cancer. Epidemiology (2006) 2.30

Night shift work and the risk of endometrial cancer. Cancer Res (2007) 2.28

A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 2.23

Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res (2006) 2.20

Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension (2002) 2.16

Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst (2002) 2.16

A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2005) 2.15

Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med (2010) 2.15

Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J Clin Oncol (2006) 2.14

Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev (2006) 2.14

Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12

Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab (2013) 2.11

Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res (2011) 2.11

Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev (2004) 2.10

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst (2011) 2.09

Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 2.09

Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat (2013) 2.07

Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab (2007) 2.07

Teenage acne and cancer risk in US women: A prospective cohort study. Cancer (2015) 2.05

High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A (2011) 2.03

Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care (2003) 2.02

Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01

Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2007) 2.01

Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer (2007) 2.01

Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol (2009) 1.99

Cigarette smoking and the incidence of breast cancer. Arch Intern Med (2011) 1.97

Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95

Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev (2007) 1.95

Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94

Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev (2002) 1.91

Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med (2004) 1.91

Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.90

Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr (2004) 1.88

Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85

Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst (2005) 1.84

Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res (2010) 1.82

Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res (2007) 1.82

A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod (2010) 1.79

Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol (2008) 1.79

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation (2004) 1.78

Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2008) 1.77

Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet (2011) 1.77

A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer (2007) 1.76

Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med (2006) 1.74

Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer. Ann Intern Med (2002) 1.73

The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med (2003) 1.71

A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation (2007) 1.70

Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine. Am J Clin Nutr (2005) 1.68

Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Am J Clin Nutr (2003) 1.68

Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology (2006) 1.67

Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res (2004) 1.67

Job stress and breast cancer risk: the nurses' health study. Am J Epidemiol (2004) 1.66

Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol (2004) 1.63

Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration. Am J Clin Nutr (2006) 1.61

Risk factors for mortality in the nurses' health study: a competing risks analysis. Am J Epidemiol (2010) 1.61

Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59

Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet (2009) 1.58